MARKET

KRYS

KRYS

Krystal Biotech
NASDAQ
221.96
+4.50
+2.07%
Pre Market: 222.80 +0.84 +0.38% 04:05 12/05 EST
OPEN
215.80
PREV CLOSE
217.46
HIGH
222.66
LOW
213.83
VOLUME
1
TURNOVER
0
52 WEEK HIGH
222.66
52 WEEK LOW
122.80
MARKET CAP
6.44B
P/E (TTM)
33.31
1D
5D
1M
3M
1Y
5Y
1D
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Benzinga · 14h ago
US High Growth Tech Stocks To Watch
Simply Wall St · 4d ago
Weekly Report: what happened at KRYS last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at KRYS last week (1117-1121)?
Weekly Report · 11/24 10:24
How Investors Are Reacting To Krystal Biotech (KRYS) Surging Revenue and Global VYJUVEK Expansion
Simply Wall St · 11/21 20:17
Krystal Biotech (KRYS): Assessing Valuation Following Strong Q3 Results and Global Expansion Moves
Simply Wall St · 11/20 15:27
Krystal Biotech treatment of Hailey-Hailey disease granted orphan status
TipRanks · 11/20 15:00
Weekly Report: what happened at KRYS last week (1110-1114)?
Weekly Report · 11/17 10:24
More
About KRYS
Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. The Company is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include KB407, KB408, KB707, KB105, KB801, KB803, KB304 and KB301. Its commercial product, VYJUVEK, is a redosable gene therapy, and a genetic medicine approved in the United States and Europe for the treatment of dystrophic epidermolysis bullosa. KB407 is being developed for the treatment of Cystic Fibrosis. KB408 is being developed for the treatment of Alpha-1 Antitrypsin Deficiency, a rare lung disease. KB707 is being developed for the treatment of solid tumors. KB105 is being developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis. KB803 is a redosable eye drop formulation of B-VEC, designed for the treatment of ocular complications.

Webull offers Krystal Biotech Inc stock information, including NASDAQ: KRYS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRYS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRYS stock methods without spending real money on the virtual paper trading platform.